Do PAI-1 and vitronectin promote or inhibit neointima formation? The exact role of the fibrinolytic system in vascular remodeling remains uncertain.
Konstantinides
Stavros
S
Schäfer
Katrin
K
Loskutoff
David J
DJ
D000818:Animals; D005342:Fibrinolysis / Q000502:physiology*; D006801:Humans; D009389:Neovascularization, Pathologic / Q000097:blood* / Q000517:prevention & control*; D018919:Neovascularization, Physiologic / Q000502:physiology*; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood / Q000172:deficiency / Q000502:physiology*; D017539:Tunica Intima / Q000378:metabolism*; D019096:Vitronectin / Q000097:blood / Q000172:deficiency / Q000502:physiology*
D017395:Plasminogen Activator Inhibitor 1; D019096:Vitronectin